Skip to main
CME
CME logo

CME Group (CME) Stock Forecast & Price Target

CME Group (CME) Analyst Ratings

Based on 35 analyst ratings
Hold
Strong Buy 17%
Buy 23%
Hold 43%
Sell 9%
Strong Sell 9%

Bulls say

CME Group has demonstrated strong financial performance with a recent quarterly dividend increase of approximately 9% year-over-year, reflecting robust free cash flow generation over 14 consecutive years. The company's trading volumes have significantly risen, highlighted by a 33% year-over-year growth in Henry Hub Natural Gas futures and a notable 307% increase in average daily volume for crypto products, indicating heightened customer demand and effective product innovation. Additionally, a growing participation in both futures and options markets, along with opportunistic share repurchases, positions CME Group favorably for sustained stock performance and shareholder value enhancement.

Bears say

CME Group has experienced adverse trading conditions, particularly in agriculture markets, with a noted decline in average daily volume (ADV) in soybean markets attributed to favorable weather in South America, potentially leading to record production. The company faces a potential earnings per share (EPS) decline of approximately 10% in a downside scenario, raising concerns about the sustainability of its market position, especially if open interest continues to decline. While the revenue from market data and information services slightly exceeded estimates, overall trading volumes and conditions remain weak, indicating that if sentiment deteriorates further, it could negatively impact CME Group's financial stability and stock value.

CME Group (CME) has been analyzed by 35 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 23% recommend Buy, 43% suggest Holding, 9% advise Selling, and 9% predict a Strong Sell.

This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CME Group (CME) Forecast

Analysts have given CME Group (CME) a Hold based on their latest research and market trends.

According to 35 analysts, CME Group (CME) has a Hold consensus rating as of Jul 23, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $213.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $213.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CME Group (CME)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.